Bayer AG (WAR:BAY) Short Interest


WAR:BAY Bayer AG WAR:BAY
51 GF Score
Price zł165.40
GF Value zł116.21
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Bayer AG Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

WAR:BAY vs LLY, JNJ, ABBV: Short Interest Comparison

For the Drug Manufacturers - General subindustry, Bayer AG's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bayer AG Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Short Interest distribution charts can be found below:

* The bar in red indicates where Bayer AG's Short Interest falls into.


WAR:BAY
51GF Score
Bayer AG WAR:BAY
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bayer AG (WAR:BAY) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of zł165.40 is trading 42.3% above its estimated GF Value™ of zł116.21. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for WAR:BAY:

  • Short Interest:
  • GF Value™: zł116.21 vs. price of zł165.40 (42.3% above fair value)
  • GF Score™: 51/100 with 2 warning signs

No single metric tells the full story. See the WAR:BAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
51GF Score

Get the complete analysis for WAR:BAY

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł165.40
Price
zł116.21
GF Value